Adding cognitive behavioral therapy to quetiapine in mood disorders is linked to reduced suicide risk and depressive symptoms ...
December 7, 2009 — The US Food and Drug Administration (FDA) has approved a new indication for quetiapine fumarate extended-release tablets (Seroquel XR, AstraZeneca Pharmaceuticals, LP), allowing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results